Atenolol

Therapeutic indications

Atenolol is indicated for:

Myocardial infarction

Population group: both men and women, only adults (18 years old or older)

Atenolol is indicated for the management of myocardial infarction for early intervention in the acute phase.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 50-100 mg once daily

Treatment 2: Intravenous - 5-10 mg once daily

Hypertension

Population group: both men and women, only adults (18 years old or older)

Atenolol is indicated in the treatment of management of hypertension.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 50-100 mg once daily

Angina pectoris

Population group: both men and women, only adults (18 years old or older)

Atenolol is indicated in the treatment of management of angina pectoris.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 100 mg given orally once daily

Treatment 2: Oral - 50 mg given twice daily

Cardiac arrhythmias

Population group: both men and women, only adults (18 years old or older)

Cardiac arrhythmia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 50-100 mg once daily

Treatment 2: Intravenous - 2.5-10mg

Treatment 3: Intravenous - 0,15mg/kg

Contraindications

Atenolol is contraindicated in the following cases:

Cardiogenic shock

Cardiogenic shock

Uncontrolled heart failure

Decompensated cardiac failure

Sick sinus syndrome

Sick sinus syndrome

Second, third-degree heart block

at least one of
Second degree atrioventricular block

Complete atrioventricular block

Untreated phaeochromocytoma

Phaeochromocytoma

Metabolic acidosis

Metabolic acidosis

Bradycardia (<45 bpm)

Bradycardia

Hypotension

Hypotension